Cosmos Health Stock Performance

COSM Stock  USD 0.79  0.01  1.25%   
The firm shows a Beta (market volatility) of -1.1, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Cosmos Health are expected to decrease slowly. On the other hand, during market turmoil, Cosmos Health is expected to outperform it slightly. At this point, Cosmos Health has a negative expected return of -0.42%. Please make sure to confirm Cosmos Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cosmos Health performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cosmos Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor
1:10
Dividend Date
2017-11-21
Last Split Date
2017-11-21
JavaScript chart by amCharts 3.21.1512345678910SepOctNov -40-30-20-100
JavaScript chart by amCharts 3.21.15Cosmos Health Cosmos Health Dividend Benchmark Dow Jones Industrial
1
Disposition of 42500 shares by Grigorios Siokas of Cosmos Health at 0.28 subject to Rule 16b-3
09/20/2024
2
Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs Mpox PCR Detection Ki...
09/23/2024
3
Cosmos Health Reports Strong 160 percent Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands
09/25/2024
4
Cosm Los Angeles hosts Dodgers NLCS watch party
10/17/2024
5
Cosmos Health files secondary offering of shares
10/28/2024
6
Dan Gilbert to bring ultra-HD TV viewing venue to downtown Detroit for live sports, events
11/01/2024
7
4D Molecular Therapeutics, Inc. Reports Q3 Loss, Lags Revenue Estimates
11/13/2024
8
ARMISTICE CAPITAL, LLC Acquires New Stake in Cosmos Health Inc
11/15/2024
9
Cosmos Health Third Quarter 2024 Earnings Misses Expectations
11/18/2024
10
Taglich Brothers Releases Updated Coverage on Cosmos Health Projects Positive EPS for 2025 and Sets 3 Price Target, Nearly 300 percent Above Current Share Price
11/26/2024
Begin Period Cash Flow20.7 M
  

Cosmos Health Relative Risk vs. Return Landscape

If you would invest  112.00  in Cosmos Health on September 4, 2024 and sell it today you would lose (32.00) from holding Cosmos Health or give up 28.57% of portfolio value over 90 days. Cosmos Health is currently does not generate positive expected returns and assumes 4.8355% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Cosmos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketCOSM 012345 -0.4-0.3-0.2-0.10.00.1
       Risk  
Given the investment horizon of 90 days Cosmos Health is expected to under-perform the market. In addition to that, the company is 6.47 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.19 per unit of volatility.

Cosmos Health Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cosmos Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cosmos Health, and traders can use it to determine the average amount a Cosmos Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0863

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCOSM

Estimated Market Risk

 4.84
  actual daily
43
57% of assets are more volatile

Expected Return

 -0.42
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cosmos Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cosmos Health by adding Cosmos Health to a well-diversified portfolio.

Cosmos Health Fundamentals Growth

Cosmos Stock prices reflect investors' perceptions of the future prospects and financial health of Cosmos Health, and Cosmos Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cosmos Stock performance.
Return On Equity-0.57
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-100%-80%-60%-40%-20%
Return On Asset-0.2
Profit Margin(0.38) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-4,000%-3,000%-2,000%-1,000%0%
Operating Margin(0.19) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-300%-200%-100%0%100%200%
Current Valuation26.27 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%10,000%20,000%30,000%40,000%
Shares Outstanding23.26 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-315,000%10,000%15,000%20,000%
Price To Earning2.41 X
Price To Book0.53 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-100%-80%-60%-40%-20%
Price To Sales0.33 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-100%-80%-60%-40%-20%0%20%40%
Revenue53.38 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%1,000%2,000%3,000%4,000%5,000%6,000%
Gross Profit8.33 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%200%400%600%800%
EBITDA(19.9 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-150,000%-100,000%-50,000%0%50,000%100,000%150,000%200,000%
Net Income(18.54 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-100,000%0%100,000%200,000%300,000%400,000%
Cash And Equivalents322.37 K
Total Debt8.23 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-315,000%10,000%15,000%20,000%
Debt To Equity4.79 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-500%0%500%
Current Ratio1.05 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-315,000%10,000%15,000%
Book Value Per Share2.27 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-30,000%-20,000%-10,000%0%10,000%20,000%
Cash Flow From Operations(15.64 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31-10,000%-5,000%0%5,000%10,000%15,000%20,000%
Earnings Per Share(2.45) X
Market Capitalization18.86 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-315,000%10,000%15,000%20,000%25,000%30,000%
Total Asset66.01 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%5,000,000%10,000,000%15,000,000%
Retained Earnings(91.64 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%500,000%1,000,000%1,500,000%2,000,000%
Working Capital12.29 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Current Asset6.37 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%2,000,000%4,000,000%6,000,000%8,000,000%10,000,000%12,000,000%
Current Liabilities1.61 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-310%100,000%200,000%300,000%400,000%500,000%600,000%700,000%

About Cosmos Health Performance

By examining Cosmos Health's fundamental ratios, stakeholders can obtain critical insights into Cosmos Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cosmos Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 35.65  48.22 
Return On Tangible Assets(0.32)(0.33)
Return On Capital Employed(0.52)(0.50)
Return On Assets(0.28)(0.29)
Return On Equity(0.51)(0.49)

Things to note about Cosmos Health performance evaluation

Checking the ongoing alerts about Cosmos Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cosmos Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cosmos Health generated a negative expected return over the last 90 days
Cosmos Health has some characteristics of a very speculative penny stock
Cosmos Health has high historical volatility and very poor performance
The company reported the previous year's revenue of 53.38 M. Net Loss for the year was (18.54 M) with profit before overhead, payroll, taxes, and interest of 8.33 M.
Cosmos Health currently holds about 322.37 K in cash with (15.64 M) of positive cash flow from operations.
Cosmos Health has a frail financial position based on the latest SEC disclosures
Roughly 16.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Taglich Brothers Releases Updated Coverage on Cosmos Health Projects Positive EPS for 2025 and Sets 3 Price Target, Nearly 300 percent Above Current Share Price
Evaluating Cosmos Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cosmos Health's stock performance include:
  • Analyzing Cosmos Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cosmos Health's stock is overvalued or undervalued compared to its peers.
  • Examining Cosmos Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cosmos Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cosmos Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cosmos Health's stock. These opinions can provide insight into Cosmos Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cosmos Health's stock performance is not an exact science, and many factors can impact Cosmos Health's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.45)
Revenue Per Share
3.733
Quarterly Revenue Growth
0.068
Return On Assets
(0.20)
Return On Equity
(0.57)
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.